• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外泌体非编码RNA:视网膜血管疾病的潜在治疗方法。

Exosomal noncoding RNA: A potential therapy for retinal vascular diseases.

作者信息

Heo Jong-Ik, Ryu Juhee

机构信息

Vessel-Organ Interaction Research Center, College of Pharmacy, Kyungpook National University, Daegu, South Korea.

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, South Korea.

出版信息

Mol Ther Nucleic Acids. 2024 Jan 24;35(1):102128. doi: 10.1016/j.omtn.2024.102128. eCollection 2024 Mar 12.

DOI:10.1016/j.omtn.2024.102128
PMID:38356865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10865410/
Abstract

Exosomes are extracellular vesicles that can contain DNA, RNA, proteins, and metabolites. They are secreted by cells and play a regulatory role in various biological responses by mediating cell-to-cell communication. Moreover, exosomes are of interest in developing therapies for retinal vascular disorders because they can deliver various substances to cellular targets. According to recent research, exosomes can be used as a strategy for managing retinal vascular diseases, and they are being investigated for therapeutic purposes in eye conditions, including glaucoma, dry eye syndrome, retinal ischemia, diabetic retinopathy, and age-related macular degeneration. However, the role of exosomal noncoding RNA in retinal vascular diseases is not fully understood. Here, we reviewed the latest research on the biological role of exosomal noncoding RNA in treating retinal vascular diseases. Research has shown that noncoding RNAs, including microRNAs, circular RNAs, and long noncoding RNAs play a significant role in the regulation of retinal vascular diseases. Furthermore, through exosome engineering, the expression of relevant noncoding RNAs in exosomes can be controlled to regulate retinal vascular diseases. Therefore, this review suggests that exosomal noncoding RNA could be considered as a biomarker for diagnosis and as a therapeutic target for treating retinal vascular disease.

摘要

外泌体是一种细胞外囊泡,可包含DNA、RNA、蛋白质和代谢产物。它们由细胞分泌,并通过介导细胞间通讯在各种生物学反应中发挥调节作用。此外,外泌体在开发视网膜血管疾病治疗方法方面具有重要意义,因为它们可以将各种物质传递到细胞靶点。根据最近的研究,外泌体可作为治疗视网膜血管疾病的一种策略,并且正在针对包括青光眼、干眼症、视网膜缺血、糖尿病视网膜病变和年龄相关性黄斑变性在内的眼部疾病进行治疗研究。然而,外泌体非编码RNA在视网膜血管疾病中的作用尚未完全明确。在此,我们综述了外泌体非编码RNA在治疗视网膜血管疾病中的生物学作用的最新研究。研究表明,包括微小RNA、环状RNA和长链非编码RNA在内的非编码RNA在视网膜血管疾病的调控中发挥着重要作用。此外,通过外泌体工程,可以控制外泌体中相关非编码RNA的表达,以调节视网膜血管疾病。因此,本综述表明,外泌体非编码RNA可被视为视网膜血管疾病诊断的生物标志物和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf0/10865410/76747f002fc6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf0/10865410/9cc55bfaef8e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf0/10865410/ae84188f9200/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf0/10865410/76747f002fc6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf0/10865410/9cc55bfaef8e/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf0/10865410/ae84188f9200/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8cf0/10865410/76747f002fc6/gr2.jpg

相似文献

1
Exosomal noncoding RNA: A potential therapy for retinal vascular diseases.外泌体非编码RNA:视网膜血管疾病的潜在治疗方法。
Mol Ther Nucleic Acids. 2024 Jan 24;35(1):102128. doi: 10.1016/j.omtn.2024.102128. eCollection 2024 Mar 12.
2
Exosomal microRNAs and long noncoding RNAs: as novel biomarkers for endometriosis.外泌体 microRNAs 和长非编码 RNAs:作为子宫内膜异位症的新型生物标志物。
Cell Tissue Res. 2023 Oct;394(1):55-74. doi: 10.1007/s00441-023-03802-5. Epub 2023 Jul 22.
3
Tumor cells-derived exosomal noncoding RNAs in cancer angiogenesis: Molecular mechanisms and prospective.肿瘤细胞衍生的外泌体非编码RNA在肿瘤血管生成中的作用:分子机制与展望
Cell Biochem Funct. 2023 Dec;41(8):1008-1015. doi: 10.1002/cbf.3874. Epub 2023 Oct 16.
4
Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications.外泌体 ncRNAs:糖尿病并发症的新型治疗靶标和生物标志物。
Pharmacol Res. 2022 Apr;178:106135. doi: 10.1016/j.phrs.2022.106135. Epub 2022 Feb 19.
5
Oncogenic Role of Exosomal Circular and Long Noncoding RNAs in Gastrointestinal Cancers.外泌体环状和长非编码 RNA 在胃肠道癌症中的致癌作用。
Int J Mol Sci. 2022 Jan 15;23(2):930. doi: 10.3390/ijms23020930.
6
Analysis of Annotated and Unannotated Long Noncoding RNAs from Exosome Subtypes Using Next-Generation RNA Sequencing.利用下一代 RNA 测序分析外泌体亚型中的注释和未注释长非编码 RNA。
Methods Mol Biol. 2021;2254:195-218. doi: 10.1007/978-1-0716-1158-6_12.
7
Molecular functions and therapeutic applications of exosomal noncoding RNAs in cancer.外泌体非编码 RNA 在癌症中的分子功能和治疗应用。
Exp Mol Med. 2022 Mar;54(3):216-225. doi: 10.1038/s12276-022-00744-w. Epub 2022 Mar 29.
8
Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications.外泌体非编码 RNA 在神经胶质瘤中的作用:生物学功能及潜在临床应用
Mol Cancer. 2020 Mar 25;19(1):66. doi: 10.1186/s12943-020-01189-3.
9
Biological functions and clinical applications of exosomal long non-coding RNAs in cancer.外泌体长链非编码 RNA 在癌症中的生物学功能和临床应用。
J Cell Mol Med. 2020 Oct;24(20):11656-11666. doi: 10.1111/jcmm.15873. Epub 2020 Sep 14.
10
The emerging roles of exosomal circRNAs in diseases.外泌体 circRNAs 在疾病中的新兴作用。
Clin Transl Oncol. 2021 Jun;23(6):1020-1033. doi: 10.1007/s12094-020-02485-6. Epub 2020 Sep 15.

引用本文的文献

1
Nanovesicular Drug Delivery Systems for Rare Ocular Diseases: Advances, Challenges, and Future Directions.用于罕见眼科疾病的纳米囊泡给药系统:进展、挑战与未来方向
AAPS PharmSciTech. 2025 Jul 23;26(7):197. doi: 10.1208/s12249-025-03159-8.
2
Emerging roles of exosomal circRNAs in non-small cell lung cancer.外泌体环状RNA在非小细胞肺癌中的新作用
J Transl Med. 2025 Apr 30;23(1):490. doi: 10.1186/s12967-025-06463-w.
3
The Role of Non-coding RNAs in Diabetic Retinopathy: Mechanistic Insights and Therapeutic Potential.非编码RNA在糖尿病视网膜病变中的作用:机制洞察与治疗潜力

本文引用的文献

1
Extracellular Vesicles in Hepatocellular Carcinoma: Progress and Challenges in the Translation from the Laboratory to Clinic.细胞外囊泡在肝细胞癌中的作用:从实验室到临床的转化进展与挑战。
Medicina (Kaunas). 2023 Sep 5;59(9):1599. doi: 10.3390/medicina59091599.
2
Management of Retinitis Pigmentosa Via Wharton's Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results.通过华通氏胶源间充质干细胞或与 Magnovision 联合治疗色素性视网膜炎:3 年的前瞻性结果。
Stem Cells Transl Med. 2023 Oct 5;12(10):631-650. doi: 10.1093/stcltm/szad051.
3
Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction.
Mol Neurobiol. 2025 Apr 1. doi: 10.1007/s12035-025-04863-z.
4
LncRNA MALAT1's role in the development of retinopathy: A review.长链非编码RNA MALAT1在视网膜病变发生发展中的作用:综述
Medicine (Baltimore). 2025 Mar 21;104(12):e41954. doi: 10.1097/MD.0000000000041954.
5
Deciphering the role of exosomal derived regulatory noncoding RNAs as potential biomarkers for diabetic retinopathy: a systematic review.解读外泌体衍生的调控性非编码RNA作为糖尿病视网膜病变潜在生物标志物的作用:一项系统综述
Int J Retina Vitreous. 2024 Dec 18;10(1):93. doi: 10.1186/s40942-024-00615-8.
6
RNA-containing extracellular vesicles in infection.感染中的含 RNA 的细胞外囊泡。
RNA Biol. 2024 Jan;21(1):37-51. doi: 10.1080/15476286.2024.2431781. Epub 2024 Nov 26.
7
Insights into the regulatory role of epigenetics in moyamoya disease: Current advances and future prospectives.对表观遗传学在烟雾病中调节作用的见解:当前进展与未来展望。
Mol Ther Nucleic Acids. 2024 Jul 19;35(3):102281. doi: 10.1016/j.omtn.2024.102281. eCollection 2024 Sep 10.
8
Natural Products in the Treatment of Retinopathy of Prematurity: Exploring Therapeutic Potentials.天然产物在早产儿视网膜病变治疗中的应用:探索治疗潜力。
Int J Mol Sci. 2024 Aug 2;25(15):8461. doi: 10.3390/ijms25158461.
9
Human Aging and Age-Related Diseases: From Underlying Mechanisms to Pro-Longevity Interventions.人类衰老与年龄相关疾病:从潜在机制到促长寿干预措施。
Aging Dis. 2024 Jun 14. doi: 10.14336/AD.2024.0280.
间充质干细胞和心肌细胞来源的外泌体治疗心肌梗死的研究进展。
Cell Commun Signal. 2023 Aug 14;21(1):202. doi: 10.1186/s12964-023-01227-9.
4
Exosomal non-coding RNAs in angiogenesis: Functions, mechanisms and potential clinical applications.血管生成中的外泌体非编码RNA:功能、机制及潜在临床应用
Heliyon. 2023 Jul 24;9(8):e18626. doi: 10.1016/j.heliyon.2023.e18626. eCollection 2023 Aug.
5
Human retinal secretome: A cross-link between mesenchymal and retinal cells.人类视网膜分泌组:间充质细胞与视网膜细胞之间的交联
World J Stem Cells. 2023 Jul 26;15(7):665-686. doi: 10.4252/wjsc.v15.i7.665.
6
The Potential of MSC-Based Cell-Free Therapy in Wound Healing-A Thorough Literature Review.基于 MSC 的无细胞治疗在伤口愈合中的潜力——一篇全面的文献综述。
Int J Mol Sci. 2023 May 27;24(11):9356. doi: 10.3390/ijms24119356.
7
Extracellular-Vesicle-Based Therapeutics in Neuro-Ophthalmic Disorders.基于细胞外囊泡的神经眼科疾病治疗方法。
Int J Mol Sci. 2023 May 19;24(10):9006. doi: 10.3390/ijms24109006.
8
Advances in development of exosomes for ophthalmic therapeutics.眼部治疗用外泌体的研究进展。
Adv Drug Deliv Rev. 2023 Aug;199:114899. doi: 10.1016/j.addr.2023.114899. Epub 2023 May 24.
9
The Role of Small Extracellular Vesicles Derived from Mesenchymal Stromal Cells on Myocardial Protection: a Review of Current Advances and Future Perspectives.间充质基质细胞衍生的小细胞外囊泡在心肌保护中的作用:当前进展与未来展望综述
Cardiovasc Drugs Ther. 2024 Dec;38(6):1111-1122. doi: 10.1007/s10557-023-07472-x. Epub 2023 May 25.
10
BMSC-Derived Exosomes Alleviate Sepsis-Associated Acute Respiratory Distress Syndrome by Activating the Nrf2 Pathway to Reverse Mitochondrial Dysfunction.骨髓间充质干细胞衍生的外泌体通过激活Nrf2通路逆转线粒体功能障碍来减轻脓毒症相关急性呼吸窘迫综合征
Stem Cells Int. 2023 Mar 31;2023:7072700. doi: 10.1155/2023/7072700. eCollection 2023.